What does this research mean for the field?

Regenerative therapy and tissue engineering represent a prospective treatment modality for end-stage heart failure, with functional performance depending on factors such as cell sources, calcium ions, cytokines, tissue matrices, cell adhesion, and vascularization. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

January 1, 2012BiomatterOpen Access

Regenerative therapy and tissue engineering for the treatment of end-stage cardiac failure

View Full Paper

Ask AI

Bookmark

Population

Patients with end-stage heart failure

Design

Review

Authors

GFGnanaprakasam Thankam Finosh MJM. JayabalanSree Chitra Thirunal Institute for Medical Sciences and Technology

Discussion

Member takes

Implication

May guide scaffold and cell choices in research; leaves open clinical translation for end-stage HF.

Structured PICO

Population

Patients with end-stage heart failure

Intervention

Regenerative therapy and tissue engineering

This review highlights the evolving role and challenges of regenerative therapy and tissue engineering as prospective treatments for end-stage heart failure.

Cite This Study

Finosh et al. (2012) studied this question.

synapsesocial.com/papers/6a1bc85b27b545b111a900dd https://doi.org/10.4161/biom.19429

Topics

Heart failure HFrEF treatment

View Full Paper

Ask AI

Bookmark

Regenerative therapy and tissue engineering for the treatment of end-stage cardiac failure

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Topics

Regenerative therapy and tissue engineering for the treatment of end-stage cardiac failure

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Also Consider

Topics

Also Consider